Sep 30, 2021

Entrada Therapeutics Q3 2021 Earnings Report

EPS
-$9.78
Previous year: -$120
-91.8%
Cash and Equivalents
$122M
Previous year: $47M
+160.1%
Free Cash Flow
-$14.9M
Previous year: -$19.8M
-24.9%
Total Assets
$132M

Entrada Therapeutics

Entrada Therapeutics